Jan Aushadhi scheme has led to savings of Rs 7416 cr for citizens this fiscal: Govt Ruchika Sharma9 Dec 2023 3:45 PM ISTThe projected sales target for 2023-24 is Rs 1,400 crore and the scheme is growing at a very fast pace garnering public trust and confidence, Khuba...
AbbVie to focus on smaller deals after buying spree Ruchika Sharma9 Dec 2023 2:30 PM ISTAbbVie said it expects to return to "robust growth" in 2025, after its recent buying spree.
Merck-Eisai endometrial cancer therapy combo fails first-line treatment trial Ruchika Sharma9 Dec 2023 1:30 PM ISTRahway: Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line...
Pfizer Elrexfio gets European Commission approval for Multiple Myeloma Ruchika Sharma9 Dec 2023 12:00 PM ISTThe conditional marketing authorization for ELREXFIO is valid in all 27 EU member states as well as Iceland, Liechtenstein, and Norway.
Dr Reddy's Labs gets 3 USFDA observations for Bachupally RnD centre Ruchika Sharma9 Dec 2023 10:57 AM ISTHyderabad: Drug major Dr Reddy's Labs, has announced that the United States Food & Drug Administration (USFDA) has issued three...
Merck to stop phase 3 trial of Keytruda plus Lynparza for lung cancer patients Ruchika Sharma8 Dec 2023 3:19 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating...
Pfizer, Valneva conclude recruitment for Phase 3 trial for Lyme Disease Vaccine candidate VLA15 Ruchika Sharma8 Dec 2023 2:30 PM ISTNew York: Pfizer Inc. and Valneva SE have announced that they have completed recruitment for the Phase 3 trial Vaccine Against Lyme for Outdoor...
Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline Ruchika Sharma8 Dec 2023 1:30 PM ISTNew Delhi: Sanofi said on Thursday it will focus on 12 potential blockbuster drug candidates and prioritise development in immunology, as it...
AbbVie to acquire Cerevel Therapeutics for USD 8.7 billion Ruchika Sharma8 Dec 2023 12:30 PM ISTNorth Chicago: AbbVie Inc. and Cerevel Therapeutics have announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its...
Operations at Natco Pharma Chennai factory temporarily disrupted due to cyclone Ruchika Sharma8 Dec 2023 11:30 AM ISTHyderabad: Natco Pharma has announced that the operations at the Company's factory located at Manali Industrial Area, Chennai, Tamil Nadu have been...
Bristol Myers Squibb Abecma approved for use in earlier lines of therapy for patients with relapsed or refractory Multiple Myeloma in Japan Ruchika Sharma7 Dec 2023 4:30 PM ISTTokyo: Bristol-Myers Squibb K.K. has announced that the company has received manufacturing and marketing approval of the supplemental New Drug...
Merck KGaA multiple sclerosis drug fails in late-stage trials Ruchika Sharma7 Dec 2023 3:30 PM ISTFrankfurt: Merck KGaA's experimental multiple sclerosis (MS) drug missed the primary goal in highly anticipated late-stage trials, dealing a...
